tiprankstipranks
Lexaria Bioscience (LEXX)
NASDAQ:LEXX
US Market

Lexaria Bioscience (LEXX) Cash flow

Compare
194 Followers

Lexaria Bioscience Cash Flow

LEXX's free cash flow for Q1 2025 was $-2.73M. For the 2025 fiscal year, LEXX's free cash flow was decreased by $1.09M and operating cash flow was $-2.73M. See a summary of the company’s cash flow.
Cash Flow
Sep 24Sep 23Sep 22Sep 21Sep 20
Operating Cash Flow
$ -4.96M$ -5.88M$ -4.88M$ -3.99M$ -2.66M
Investing Cash Flow
$ -188.60K$ -169.61K$ -180.64K$ 193.88K$ -26.84K
Financing Cash Flow
$ 10.32M$ 1.59M$ -44.60K$ 13.42M$ 2.70M
End Cash Position
$ 6.50M$ 1.35M$ 5.81M$ 10.92M$ 1.29M
Free Cash Flow
$ -4.96M$ -6.05M$ -5.01M$ -4.07M$ -2.70M
Currency in USD

Lexaria Bioscience Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis